Zobrazeno 1 - 10
of 767
pro vyhledávání: '"Clouse KA"'
Autor:
Gao C; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Ouyang W; Division of Biotechnology Review and Research 2, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Kutza J; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Grimm TA; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Fields K; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Lankford CSR; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Schwartzkopff F; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Paciga M; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Stantchev T; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Tiffany L; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA., Strebel K; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Clouse KA; Division of Biotechnology Review and Research 1, Office of Biotechnology Products, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
Publikováno v:
Viruses [Viruses] 2023 Oct 27; Vol. 15 (11). Date of Electronic Publication: 2023 Oct 27.
Autor:
Alexandra Da Fonte M; Department of Special Education, Vanderbilt University, Nashville, TN, USA., Boesch MC; Department of Educational Psychology, University of North Texas, Denton, TX, USA., DeLuca ER; Department of Special Education, Vanderbilt University, Nashville, TN, USA., Papp SK; Department of Special Education, Vanderbilt University, Nashville, TN, USA., Mohler AE; Department of Special Education, Vanderbilt University, Nashville, TN, USA., Holmes EE; Department of Special Education, Vanderbilt University, Nashville, TN, USA., Clouse KA; Department of Special Education, Vanderbilt University, Nashville, TN, USA., Young RD; Department of Special Education, Vanderbilt University, Nashville, TN, USA., Urbano R; Vanderbilt Kennedy Center, Nashville, TN, USA.
Publikováno v:
Augmentative and alternative communication (Baltimore, Md. : 1985) [Augment Altern Commun] 2022 Mar; Vol. 38 (1), pp. 29-40. Date of Electronic Publication: 2022 Mar 25.
Autor:
Edwards V; Division of Biotechnology Review and Research I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Office of Biotechnology Products, Office of Pharmaceutical Quality, Silver Spring, MD 20993, USA., Smith DL; Division of Biotechnology Review and Research I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Office of Biotechnology Products, Office of Pharmaceutical Quality, Silver Spring, MD 20993, USA., Meylan F; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892, USA., Tiffany L; Division of Biotechnology Review and Research I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Office of Biotechnology Products, Office of Pharmaceutical Quality, Silver Spring, MD 20993, USA., Poncet S; Division of Biotechnology Review and Research I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Office of Biotechnology Products, Office of Pharmaceutical Quality, Silver Spring, MD 20993, USA., Wu WW; Facility for Biotechnology Resources, Center for Biologicals Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Phue JN; Facility for Biotechnology Resources, Center for Biologicals Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Santana-Quintero L; U.S. Food and Drug Administration, Center for Biologics Evaluation & Research, Office of Biostatistics and Epidemiology, HIVE, Silver Spring, MD 20993, USA.; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Hematology and Oncology Products, Silver Spring, MD 20993, USA., Clouse KA; Division of Biotechnology Review and Research I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Office of Biotechnology Products, Office of Pharmaceutical Quality, Silver Spring, MD 20993, USA., Gabay O; Division of Biotechnology Review and Research I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Office of Biotechnology Products, Office of Pharmaceutical Quality, Silver Spring, MD 20993, USA.
Publikováno v:
Microorganisms [Microorganisms] 2021 Dec 30; Vol. 10 (1). Date of Electronic Publication: 2021 Dec 30.
Autor:
Ouyang W; Division of Biotechnology Review and Research II, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Xie T; Division of Biotechnology Review and Research II, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Fang H; Division of Biotechnology Review and Research II, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Gao C; Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Stantchev T; Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Clouse KA; Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Yuan K; Division of Biotechnology Review and Research III, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Ju T; Division of Biotechnology Review and Research III, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA., Frucht DM; Division of Biotechnology Review and Research II, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 14; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 14.
Autor:
Gabay O; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA. Electronic address: Odile.Engel@fda.hhs.gov., Vicenty J; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA., Zack-Taylor A; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA., Tiffany L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA., Wunderlin G; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA., Smith D; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA., Reyes-Munoz L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA., Edwards V; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA., Wu WW; U.S. Food and Drug Administration, Center for Biologicals Evaluation and Research, Facility for Biotechnology Resources, Silver Spring, MD, USA., Phue JN; U.S. Food and Drug Administration, Center for Biologicals Evaluation and Research, Facility for Biotechnology Resources, Silver Spring, MD, USA., Santana-Quintero L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Hematology and Oncology Products, Silver Spring, MD, USA., Lam PV; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology, HIVE, Silver Spring, MD, USA., Clouse KA; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Biotechnology Review and Research 1, Silver Spring, MD, USA.
Publikováno v:
Joint bone spine [Joint Bone Spine] 2020 Mar; Vol. 87 (2), pp. 175-178. Date of Electronic Publication: 2019 Sep 09.
Autor:
Gabay O; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Biotechnology Review and Research 1, Silver Spring, MD 20993, USA., Vicenty J; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Biotechnology Review and Research 1, Silver Spring, MD 20993, USA., Smith D; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Biotechnology Review and Research 1, Silver Spring, MD 20993, USA., Tiffany L; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Biotechnology Review and Research 1, Silver Spring, MD 20993, USA., Ascher J; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Management, Division of Veterinary Services, Silver Spring, MD 20993, USA., Curry T; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Management, Division of Veterinary Services, Silver Spring, MD 20993, USA., Dennis J; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Management, Division of Veterinary Services, Silver Spring, MD 20993, USA., Clouse KA; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Biotechnology Review and Research 1, Silver Spring, MD 20993, USA.
Publikováno v:
Methods and protocols [Methods Protoc] 2020 Feb 22; Vol. 3 (1). Date of Electronic Publication: 2020 Feb 22.
Autor:
Stantchev TS; Division of Biotechnology Review and Research 1 (DBRR1), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD 20993, USA. tzanko.stantchev@fda.hhs.gov., Zack-Taylor A; Division of Biotechnology Review and Research 1 (DBRR1), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD 20993, USA. autumn.zack-taylor@fda.hhs.gov., Mattson N; Division of Biotechnology Review and Research 1 (DBRR1), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD 20993, USA. nicholas.mattson@fda.hhs.gov., Strebel K; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20814, USA. kstrebel@niaid.nih.gov., Broder CC; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD 20814, USA. christopher.broder@usuhs.edu., Clouse KA; Division of Biotechnology Review and Research 1 (DBRR1), Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Silver Spring, MD 20993, USA. kathleen.clouse@fda.hhs.gov.
Publikováno v:
Viruses [Viruses] 2019 Sep 23; Vol. 11 (10). Date of Electronic Publication: 2019 Sep 23.
Autor:
Manning MC; Legacy BioDesign LLC, Johnstown, CO, USA. manning@legacybiodesign.com.; Department of Chemistry, Colorado State University, Fort Collins, CO, USA. manning@legacybiodesign.com., Holcomb RE; Legacy BioDesign LLC, Johnstown, CO, USA.; Department of Chemistry, Colorado State University, Fort Collins, CO, USA., Payne RW; Legacy BioDesign LLC, Johnstown, CO, USA.; Department of Chemistry, Colorado State University, Fort Collins, CO, USA., Stillahn JM; Legacy BioDesign LLC, Johnstown, CO, USA.; Department of Chemistry, Colorado State University, Fort Collins, CO, USA., Connolly BD; Spyre Therapeutics, Inc., Waltham, MA, USA., Katayama DS; Samsung Biologics, 201-2, Songdo-Dong, Yeonsu-Gu, Incheon, Korea., Liu H; Scholar Rock, Inc., Cambridge, MA, USA., Matsuura JE; Jim Matsuura Pharma Consulting LLC, Lafayette, CO, USA., Murphy BM; Just-Evotec, Seattle, WA, USA., Henry CS; Department of Chemistry, Colorado State University, Fort Collins, CO, USA., Crommelin DJA; Utrecht University, Utrecht, Netherlands.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Jul; Vol. 41 (7), pp. 1301-1367. Date of Electronic Publication: 2024 Jun 27.
Autor:
Agrawal A; Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD 20993, USA. anant.agrawal@fda.hhs.gov., Majdi J; Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD 20993, USA. joemajdi@yahoo.com., Clouse KA; Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. kathleen.clouse@fda.hhs.gov., Stantchev T; Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. tzanko.stantchev@fda.hhs.gov.
Publikováno v:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2018 May 23; Vol. 18 (6). Date of Electronic Publication: 2018 May 23.
Autor:
Rezaei, Sahar1,2,3, Timani, Khalid A.1,2,3, He, Johnny J.1,2,3 johnny.he@rosalindfranklin.edu
Publikováno v:
Aging & Disease. Apr2024, Vol. 15 Issue 2, p831-850. 20p.